| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/04/2003 | US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166061 14273 receptor, a novel G-protein coupled receptor |
| 09/04/2003 | US20030166057 Method and apparatus for the production of soluble MHC antigens and uses thereof |
| 09/04/2003 | US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases |
| 09/04/2003 | US20030166038 Using gamma-glutamyl transpeptidase concentration in urine as marker to accurately diagnose bone disorders and determine osteoporotic fracture risk |
| 09/04/2003 | US20030166036 Protease and an aminopeptidase associated with development of benign prostatic hyperplasia (BPH) |
| 09/04/2003 | US20030166035 Single use analytical device comprising barium sulphate dispersion for detection and measurement of enzymatic activity in liquids |
| 09/04/2003 | US20030166033 Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type l collagen metabolites |
| 09/04/2003 | US20030166032 Measuring unmineralized collagen/telopeptides in vivo via detecting antibody binding |
| 09/04/2003 | US20030166031 Assay for anti-INGAP antibodies |
| 09/04/2003 | US20030166030 Methods to study and mechanisms of biofilm-related antibiotic resistance |
| 09/04/2003 | US20030166029 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 09/04/2003 | US20030166028 Peptide biosensors for anthrax protease |
| 09/04/2003 | US20030166027 Comprises four campylobacter proteins in combination for monitoring and detecting bacterial infections |
| 09/04/2003 | US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy |
| 09/04/2003 | US20030166023 Using genetic sensitivity markers to determine if taxol can be used to reduce the propagation of tumors |
| 09/04/2003 | US20030166019 Immunoglobulin for use in diagnosis of nervous system and psychological disorders |
| 09/04/2003 | US20030166018 Detecting modulators which reduce granule polypeptide (SWAP-70) in mast cells for treating allergies and asthma |
| 09/04/2003 | US20030166017 Using thrombospondin markers to diagnose stroke, atherosclerosis, coronary heart disease and congestive heart failure |
| 09/04/2003 | US20030166016 Assay methods for cyclin dependent kinases |
| 09/04/2003 | US20030166015 Monitoring, measuring and detecting modulators of cell and substrate activity; cancer diagnosis; anticarcinogenic agents |
| 09/04/2003 | US20030166014 Using concentration of haptoglobin (endo-1) to diagnosis urogenital disorders; immunoassay; fertility evaluation |
| 09/04/2003 | US20030166010 Isolating modified antibody for use as affinity ligand in gel, bead or microarray separation of proteins and/or peptides |
| 09/04/2003 | US20030166009 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey |
| 09/04/2003 | US20030166007 Using mass spectrometry to identify and isolate protein targets of chemical compounds; high throughput assay; drug screening |
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/04/2003 | US20030166002 Formed by reductively aminating triazine, then adding amine to cyanuric chloride; for proteomics and sensors |
| 09/04/2003 | US20030166001 Identifying modulators of signal tranduction; immunostimulants; immunomodulators |
| 09/04/2003 | US20030165996 Producing protein with altered immunogenicity or improved stability/in situ half-life; veterinary medicine; pharmacology |
| 09/04/2003 | US20030165994 Device and method for multiparallel synthesis and screening |
| 09/04/2003 | US20030165993 Human antibodies as detection reagents |
| 09/04/2003 | US20030165992 Method for detecting a predisposition to asthma and atopy |
| 09/04/2003 | US20030165991 Peptide mimotope to mycotoxin deoxynivalenol and uses thereof |
| 09/04/2003 | US20030165987 Compositions and methods for surface imprinting |
| 09/04/2003 | US20030165986 Methods of use of the TACI/TACI-L interaction |
| 09/04/2003 | US20030165985 Identifying modulators of NF-kappaB essential modulator (NEMO) and tumor suppressor protein (CYLD) binding activity for treating immunological, cancer and inflammatory disorders |
| 09/04/2003 | US20030165983 Proteomic determination of protein nitrotyrosine modifications using mass spectrometry |
| 09/04/2003 | US20030165982 Propagation and quantification of nucleotide sequences for detecting infection and diagnosing genetic disorders |
| 09/04/2003 | US20030165978 Comparing nucleotide sequences of individuals manifesting similar phenotypes using genomic mismatch scanning (GMS); genetic mapping; disease diagnosis |
| 09/04/2003 | US20030165974 Detecting cell proliferation disorders of lung, liver and/or pancreas which are associated with tumor suppressor lung cancer 1 polypeptide (TSLC1) |
| 09/04/2003 | US20030165973 Identifying modulators of peroxisome proliferator activated receptors gamma coactivator-1 (PGC-1) for preventing or treating cancer, obesity, cardiovascular, diabetic and chronic obstructive pulmonary diseases |
| 09/04/2003 | US20030165970 Bioassay for concurrent identifcation of Hepatitis viral diseases, syphilis and lymphadenopathy associated viral infections |
| 09/04/2003 | US20030165967 APM1 biallelic markers and uses thereof |
| 09/04/2003 | US20030165966 MSRAs as modifiers of the p53 pathway and methods of use |
| 09/04/2003 | US20030165963 Comprises microarray of immobilized oligonucleotides for transcription, amplification and hybridization analysis |
| 09/04/2003 | US20030165962 Comprises biotin/avidin immobilized macromolecules for converting, separating or concentrating microorganism, proteins and/or nucleic acids |
| 09/04/2003 | US20030165961 UV excitable energy transfer reagents |
| 09/04/2003 | US20030165960 Using electrokinetics to determining the rate or extent of a reaction or assay in a multichannel microarray |
| 09/04/2003 | US20030165958 Test and model for Alzheimer's disease |
| 09/04/2003 | US20030165955 Such as bis-acylated fluorescein for use as reporter molecules for detecting cell entry by molecules; high throughput screeening; solid phase synthesis |
| 09/04/2003 | US20030165954 Preparing drug sensitivity patterns for people diagnosed with tumors; monitoring effectiveness of antitumor agents; drug screening; side effect reduction |
| 09/04/2003 | US20030165951 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/04/2003 | US20030165950 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in |
| 09/04/2003 | US20030165943 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae |
| 09/04/2003 | US20030165940 Diagnosing tumors via detection of allelic mutation in adenomatous polyposis coli gene |
| 09/04/2003 | US20030165937 Diagnosing muscular dystrophies based on concentration of dysferlin in blood; immunoassay |
| 09/04/2003 | US20030165935 Quantitating target nucleotide sequences using labeled probes; forensics; infection diagnosis; heredity testing; organ transplantation |
| 09/04/2003 | US20030165932 Autoinducer is not an acyl-homoserine lactone and can interact with the Vibrio harveyi LuxQ protein, increasing expression of the operon; drug screening |
| 09/04/2003 | US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 09/04/2003 | US20030165928 Susceptibility to bone damage |
| 09/04/2003 | US20030165927 Identifying fetal cell nuclei, chromosomes or DNA in a maternal blood or vaginal sample; detecting chromosomal aberrations |
| 09/04/2003 | US20030165925 Diagnostic probe detection system |
| 09/04/2003 | US20030165924 Comprises nucleotide sequences transcribed in cells which accumulate multiple intracellular lipid droplets for diagnosing atherosclerosis |
| 09/04/2003 | US20030165922 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/04/2003 | US20030165920 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 09/04/2003 | US20030165919 Using fluorescence resonance energy transfer (FRET) to monitor CD14 receptor cluster and diagnose inflammatory diseases |
| 09/04/2003 | US20030165915 Polynucleotide or polypeptide, as well as methods for determining whether a particular site in a target molecule is at or near the ligand binding site, are provided. Ligand binding affinities corresponding to both the target molecule |
| 09/04/2003 | US20030165914 Fluorescent in situ hybridization (oligonucleotide-flavin conjugates are incubated with cDNA); genome sequencing |
| 09/04/2003 | US20030165911 Determining presence or absence of target CDNA/messenger RNA using restriction endonuclease recognition sequence (RERS), oligonuclelotides and nucleotide sequence amplification; detecting low levels of transcription |
| 09/04/2003 | US20030165909 Screening cell sample for presence of lung nucleotide sequences (LS170) for diagnosing, classifying, monitoring, prognosing, in situ imaging, preventing or treating lung diseases, tumors or metastases |
| 09/04/2003 | US20030165907 Human glycine transporter type 2 |
| 09/04/2003 | US20030165905 Polymer coated surfaces for microarray applications |
| 09/04/2003 | US20030165903 Comprises fusion proteins containing histone acetyltransferase/deacetyltransferase activity for chromatin remodeling in plant and animal tissues; gene expression inhibition |
| 09/04/2003 | US20030165898 Method for concurrent amplification and real time detection of polymorphic nucleic acid sequences |
| 09/04/2003 | US20030165887 Diagnosing tumors by monitor concentration and expression of tumor up regulated card containing antagonist of caspase nine (TUCAN) polypeptides; monitoring success of treatments with antitumor agents |
| 09/04/2003 | US20030165882 Preparing spheres comprised of matrix and channels with immobilized macromolecules such as polynucleotides, proteins or polysaccharides on surface for use as capture tools in chromatographic separation and immunoassays |
| 09/04/2003 | US20030165879 Identifying nucleic acids coding tissue specific odorant binding protein (OBP) and its agonists/antagonists; for controlling insect feeding and breeding behavior, eliminating odors, detecting small molecules in air; tissue engineering |
| 09/04/2003 | US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 09/04/2003 | US20030165873 For isolating ligand binding polypeptides; fusion proteins; drug screening; kits; surface plasmon resonance |
| 09/04/2003 | US20030165869 Computer algorithm for automatic allele determination from fluorometer genotyping device |
| 09/04/2003 | US20030165865 Methods of analysis of nucleic acids |
| 09/04/2003 | US20030165860 Classifying and detection of campylobacter using VA1/R probes/primers to virulence determinant genes (VACA/VDG) |
| 09/04/2003 | US20030165853 Using peptide nucleic acids to monitor blood brain permeability and in situ gene expression in vertebrate nervous tissue |
| 09/04/2003 | US20030165852 Screening fetal blood and detecting single gene disorders such as sickle-cell anemia, thalassemia, muscular dystrophy or cystic fibrosis using nucleotide sequence probes; colorimetric analysis |
| 09/04/2003 | US20030165850 Nucleic acid molecules comprising the promoter for PCA3dd3, a new prostate antigen, and uses thereof |
| 09/04/2003 | US20030165843 Microarray for profiling gene expression in cells and tissues; antisense agents; antitumor agents |
| 09/04/2003 | US20030165842 Method for identifying biological binding molecules and apparatus for carrying out the method |
| 09/04/2003 | US20030165836 Using computer and allelic marker for mapping genetic disorder to preferential region on chromosome |
| 09/04/2003 | US20030165835 Cell stress regulated human MHC class I gene |
| 09/04/2003 | US20030165834 Using colon cancer associated polypeptides (CCP) for diagnosing and detecting rectal tumors; immunoassays |
| 09/04/2003 | US20030165833 Hybridization probes and oligonucleotides used for quantitative analysis fo ribosomal nucleic acids from yeast |
| 09/04/2003 | US20030165832 Genetic replication of DNA contained in samples, then detecting and analyzing using fluorescent resonance energy transfer(FRET) hybridization probes, in kits; quantitative analysis |
| 09/04/2003 | US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents |
| 09/04/2003 | US20030165825 Identifying oligopeptides using interaction-dependent enzyme activation system; high-throughput assay |
| 09/04/2003 | US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 09/04/2003 | US20030165817 Diagnostic assay |